Featured Research

from universities, journals, and other organizations

Researchers trace HIV mutations that lead to drug resistance

Date:
January 12, 2010
Source:
University of California - San Diego
Summary:
Researchers have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.

Computers and a statistical screen allowed Wei Wang to trace mutations in HIV that lead to drug resistance.
Credit: UC San Diego

Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.

"We want to crack the code of resistance," said Wei Wang, associate professor chemistry and biochemistry at UC San Diego who led the collaboration along with Jun Liu of Harvard. The team reports their work in the early online edition of the Proceedings of the National Academy of Sciences.

HIV replicates quickly, but the copies are imprecise. The constant mutation has made HIV infection difficult to treat, much less cure, because drugs designed to interrupt the cycle of infection fail when their targets change.

To better understand which mutations matter for drug resistance, the researchers compared sequences of HIV taken from patients treated with specific drugs to those from untreated patients. Using a novel statistical method, they identified clusters of mutations that seemed to be working together to help the virus escape treatment.

One drug, indinavir, targets a protein called protease, which the virus needs to assemble the capsule it uses to invade new cells. Substitutions in ten different places on protease occurred in patients who were taking the drug, but what combination of mutations would hinder the action of the drug wasn't clear before this analysis.

Chemists can determine how a drug fits to a particular protein using computer modeling, but those computations take considerable time. Evaluating all possible combinations of those 10 substitutions is impractical. The statistical screen narrowed down the possibilities.

"People never looked at this, because they didn't know which mutation or which combination of mutations to study," Wang said. "That's the advantage of using the statistical method first to find the patterns. After the statisticians discovered the connections between mutations, then we focused on those combinations. We built structural models to understand the molecular basis of drug resistance."

Using the computing resources of the Center for Theoretical Biological Physics at UC San Diego where Wang is a senior scientist, they worked out how the substitutions would change the shape of protease and its affinity for the drug. One set of changes, for example, would tend to dislodge the drug from the pocket where it normally fits.

The researchers also determined that the mutations must happen in a particular order for replicants to survive treatment with indinavir, a window into how drug resistance develops.

Looking back into the database at samples taken from individual patients at several different times during the course of their treatment, the team found that mutations accumulated in the orders that they predicted would be possible during drug treatment. Sequential mutations that their models predicted would leave the virus vulnerable to drug treatment were not observed.

The team reports its results for two additional drugs, zidovudine and nevirapine, which target a different viral enzyme, in this paper and is extending its work to all nine drugs currently approved by the FDA to treat HIV.

Additional authors include Jing Zhang at Harvard University and Tingjun Hou, a former postdoctoral fellow at UC San Diego now at Soochow University in Suzhou, China. Grants from the National Science Foundation and the National Institutes of Health supported this work.


Story Source:

The above story is based on materials provided by University of California - San Diego. The original article was written by Susan Brown. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Diego. "Researchers trace HIV mutations that lead to drug resistance." ScienceDaily. ScienceDaily, 12 January 2010. <www.sciencedaily.com/releases/2010/01/100111154918.htm>.
University of California - San Diego. (2010, January 12). Researchers trace HIV mutations that lead to drug resistance. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2010/01/100111154918.htm
University of California - San Diego. "Researchers trace HIV mutations that lead to drug resistance." ScienceDaily. www.sciencedaily.com/releases/2010/01/100111154918.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins